RecruitingPhase 2NCT07220603

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Studying Myotonic dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PepGen Inc
Intervention
PGN-EDODM1(drug)
Enrollment
48 enrolled
Eligibility
All sexes
Timeline
20252029

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07220603 on ClinicalTrials.gov

Other trials for Myotonic dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Myotonic dystrophy

← Back to all trials